Israel’s early determination to fully vaccinate its population—when two shots were defined as fully vaccinated—led to it being heralded as a huge success story. But suddenly, the coronavirus cases are back, and with a vengeance.
Without high vaccination levels, the Centres for Disease Control and Prevention won’t reach the levels it believes are needed to reach herd immunity. That might be a blessing in disguise.
Regulating vaccines under the same liability regime as all other pharmaceuticals, and acknowledging problems as well as benefits associated with them, will likely lead to safer vaccines and a better informed public.
Why are America’s Tier 1A workers the most likely to refuse vaccination? Gallup, and numerous other surveys and reports, produce unexpected results.
It would be foolhardy to base public policy decisions on the unrealistic prospect of a quick-fix vaccine.
Governments have vast financial interests that skew their medical research.
A documentary on the mother of all medical controversies.
Rolling back the government advantages given vaccines would level the R&D playing field and help end the drought in pharmaceutical breakthroughs.
Many conservatives have had a blind spot when it comes to vaccination, accepting as dogma studies from government bodies.
Mass vaccination advocates rely on ‘herd immunity’ to make their case. But it doesn’t exist.